Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy Highlighting a <em>Fluorescence-in-situ-Hybridization</em> Circulating Tumor Cell Approach
Lung cancer (LC), is the most common and lethal cancer worldwide. It affects both sexes and in its early stages is clinically silent, until it reaches a more advanced stage, when it becomes highly incurable. In order to improve the high mortality associated with LC there has been an urgent need for...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76855 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy Highlighting a <em>Fluorescence-in-situ-Hybridization</em> Circulating Tumor Cell Approach
- Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer
- Development of nanoparticle complexes as liquid biopsy candidates for circulating tumor cell detection
- Cluster-based human-in-the-loop strategy for improving machine learning-based circulating tumor cell detection in liquid biopsy
- FISH Probe Counting in Circulating Tumor Cells
- Lung Tumor Microenvironment and Myelomonocytic Cells
- Future Aspects of Prostate Biopsy – The Use of Primary Circulating Prostate Cells to Select Patients for Prostate Biopsy: Evidence, Utility and Cost-Benefit